Olivier Facy
Research Subjects
Olivier Facy has a total of 60 co-authors. Here are the top co-authors by number of shared publications:
- Pablo Ortega-Deballon
Université Bourgogne Europe, CHU Dijon Bourgogne, Department of Gastrointestinal Surgery, Dijon, France
10 shared publications Patrick Rat
Department of Digestive Surgery, Dijon University Hospital, 14, Rue Paul Gaffarel, 21079, Dijon Cedex, France
7 shared publicationsBrice Paquette
Department of Digestive Surgery, Besançon University Hospital, Besançon, France
3 shared publications- François Ghiringhelli
Department of Medical Oncology, Centre Georges François Leclerc, Dijon, France
3 shared publications - Boris Guiu
Department of Radiology, St-Eloi University Hospital, Montpellier, France
2 shared publications David Orry
Department of Surgery, Anticancer Centre "Georges-François Leclerc", Dijon, France
2 shared publications
Latest Publications
- Open Access
Management and Outcomes of Pancreatic Cancer in French Real-World Clinical Practice
Background: Our objective was to describe real-world patterns of care and outcomes in pancreatic cancer. Methods: 912 patients diagnosed with pancreatic cancer from 2014 to 2017 were registered by the population-based cancer registry of Burgundy (France). Progression-free and net survival were estimated. Results: at diagnosis, 52% of tumors were associated with metastases. Among the 20% of patients fulfilling resectability criteria, half of those aged 75–84 years and none of those ≥85 years actually underwent resection. Age was not associated with 3-year observed survival in patients who underwent resection. Overall, 77% of patients aged <75 years, 55% of those aged 75–84 years and 8% of those ≥85 years received chemotherapy. Among patients who were offered chemotherapy, 73% of those aged ≥85 years refused. Chemotherapy toxicity was higher with Gemcitabine_Oxaliplatin/Gemcitabine_Abraxane and FOLFIRINOX than with Gemcitabine alone. Patients resected after induction FOLFIRINOX and those treated with adjuvant Gemcitabine presented the lowest risk of progression. Three-year net survival was 35% in patients with non-metastatic resectable tumors and under 10% for other patients. Conclusions: Only half of patients aged 75–84 years with a resectable tumor actually underwent resection. Two thirds of patients aged ≥85 years refused chemotherapy, thus underlining the need to expand geriatric assessments.
Open AccessManagement and Outcomes of Pancreatic Cancer in French Real-World Clinical Practice
Background: Our objective was to describe real-world patterns of care and outcomes in pancreatic cancer. Methods: 912 patients diagnosed with pancreatic cancer from 2014 to 2017 were registered by the population-based cancer registry of Burgundy (France). Progression-free and net survival were estimated. Results: at diagnosis, 52% of tumors were associated with metastases. Among the 20% of patients fulfilling resectability criteria, half of those aged 75–84 years and none of those ≥85 years actually underwent resection. Age was not associated with 3-year observed survival in patients who underwent resection. Overall, 77% of patients aged <75 years, 55% of those aged 75–84 years and 8% of those ≥85 years received chemotherapy. Among patients who were offered chemotherapy, 73% of those aged ≥85 years refused. Chemotherapy toxicity was higher with Gemcitabine_Oxaliplatin/Gemcitabine_Abraxane and FOLFIRINOX than with Gemcitabine alone. Patients resected after induction FOLFIRINOX and those treated with adjuvant Gemcitabine presented the lowest risk of progression. Three-year net survival was 35% in patients with non-metastatic resectable tumors and under 10% for other patients. Conclusions: Only half of patients aged 75–84 years with a resectable tumor actually underwent resection. Two thirds of patients aged ≥85 years refused chemotherapy, thus underlining the need to expand geriatric assessments.
- 6 April 2017
- Published by Springer Nature in International Journal of Colorectal Disease
- Vol. 32 (6) , 857-863
Inflammatory markers as early predictors of infection after colorectal surgery: the same cut-off values in laparoscopy and laparotomy?
Purpose C-reactive protein and procalcitonin are reliable early predictors of infection after colorectal surgery. However, the inflammatory response is lower after laparoscopy as compared to open surgery. This study analyzed whether a different cutoff value of inflammatory markers should be chosen according to the surgical approach. Methods A prospective, observational study included consecutive patients undergoing elective colorectal surgery in three academic centers. All infections until postoperative day (POD) 30 were recorded. The inflammatory markers were analyzed daily until POD 4. Areas under the ROC curve and diagnostic values were calculated in order to assess their accuracy as a predictor of intra-abdominal infection. Results Five-hundred-one patients were included. The incidence of intra-abdominal infection was 11.8%. The median levels of C-reactive protein (CRP) and procalcitonin (PCT) were lower in the laparoscopy group at each postoperative day (p < 0.0001). In patients without intra-abdominal infection, they were also lower in the laparoscopy group (p = 0.0036) but were not different in patients presenting with intra-abdominal infections (p = 0.3243). In the laparoscopy group, CRP at POD 4 was the most accurate predictor of overall and intra-abdominal infection (AUC = 0.775). With a cutoff of 100 mg/L, it yielded 95.7% negative predictive value, 75% sensitivity, and 70.3% specificity for the detection of intra-abdominal infection. Conclusion The impact of infection on inflammatory markers is more important than that of the surgical approach. Defining a specific cutoff value for early discharge according to the surgical approach is not justified. A patient with CRP values lower than 100 mg/L on POD 4 can be safely discharged.
- 6 April 2017
- Published by Springer Nature in International Journal of Colorectal Disease
- Vol. 32 (6) , 857-863
Inflammatory markers as early predictors of infection after colorectal surgery: the same cut-off values in laparoscopy and laparotomy?
Purpose C-reactive protein and procalcitonin are reliable early predictors of infection after colorectal surgery. However, the inflammatory response is lower after laparoscopy as compared to open surgery. This study analyzed whether a different cutoff value of inflammatory markers should be chosen according to the surgical approach. Methods A prospective, observational study included consecutive patients undergoing elective colorectal surgery in three academic centers. All infections until postoperative day (POD) 30 were recorded. The inflammatory markers were analyzed daily until POD 4. Areas under the ROC curve and diagnostic values were calculated in order to assess their accuracy as a predictor of intra-abdominal infection. Results Five-hundred-one patients were included. The incidence of intra-abdominal infection was 11.8%. The median levels of C-reactive protein (CRP) and procalcitonin (PCT) were lower in the laparoscopy group at each postoperative day (p < 0.0001). In patients without intra-abdominal infection, they were also lower in the laparoscopy group (p = 0.0036) but were not different in patients presenting with intra-abdominal infections (p = 0.3243). In the laparoscopy group, CRP at POD 4 was the most accurate predictor of overall and intra-abdominal infection (AUC = 0.775). With a cutoff of 100 mg/L, it yielded 95.7% negative predictive value, 75% sensitivity, and 70.3% specificity for the detection of intra-abdominal infection. Conclusion The impact of infection on inflammatory markers is more important than that of the surgical approach. Defining a specific cutoff value for early discharge according to the surgical approach is not justified. A patient with CRP values lower than 100 mg/L on POD 4 can be safely discharged.
- 1 November 2016
- Published by Elsevier in Journal of Visceral Surgery
- Vol. 153 (5) , 385-386
Robotic-assisted Roux-en-Y cystojejunostomy for pancreatic pseudocyst (with video)
- 1 November 2016
- Published by Elsevier in Journal of Visceral Surgery
- Vol. 153 (5) , 385-386
Robotic-assisted Roux-en-Y cystojejunostomy for pancreatic pseudocyst (with video)
- 1 October 2015
- Published by Elsevier in Journal de Chirurgie Viscérale
- Vol. 152 (5) , A14
Détection précoce des infections après chirurgie colorectale par les marqueurs inflammatoires biologiques
- 1 October 2015
- Published by Elsevier in Journal de Chirurgie Viscérale
- Vol. 152 (5) , A14
Détection précoce des infections après chirurgie colorectale par les marqueurs inflammatoires biologiques
- 1 October 2015
- Published by Elsevier in Journal de Chirurgie Viscérale
- Vol. 152 (5) , A31
Intérêt du Ca 19.9 préopératoire dans l’évaluation de la résécabilité des cancers du pancréas
- 1 October 2015
- Published by Elsevier in Journal de Chirurgie Viscérale
- Vol. 152 (5) , A31
Intérêt du Ca 19.9 préopératoire dans l’évaluation de la résécabilité des cancers du pancréas
- 1 November 2013
- Published by Elsevier in Clinics and Research in Hepatology and Gastroenterology
- Vol. 37 (5) , 530-534
Interest of intraoperative ultrasonography during pancreatectomy for metastatic renal cell carcinoma
- 1 November 2013
- Published by Elsevier in Clinics and Research in Hepatology and Gastroenterology
- Vol. 37 (5) , 530-534
Interest of intraoperative ultrasonography during pancreatectomy for metastatic renal cell carcinoma
- Open Access
- 27 April 2012
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 99 (8) , 1072-1075
Diagnosis of postoperative pancreatic fistula
Background: Pancreatic fistula (PF) is a major source of morbidity after pancreatectomy. The International Study Group on Pancreatic Fistula (ISGPF) defines postoperative fistula by an amylase concentration in the abdominal drain of more than three times the serum value on day 3 or more after surgery. However, this definition fails to identify some clinical fistulas. This study examined the association between lipase measured in abdominal drainage fluid and PF. Methods: Amylase and lipase levels in the abdominal drain were measured 3 days after pancreatic resection. Grade B and C fistulas were classified as clinical fistulas, regardless of whether the measured amylase concentration was considered positive or negative. The PF group included patients with a clinical fistula and/or those with positive amylase according to the ISGPF definition. Results: Sixty-five patients were included. The median level of lipase was higher in patients with positive amylase than in those with negative amylase: 12 176 versus 64 units/l (P < 0·001). The lipase level was 16 500 units/l in patients with a clinical fistula and 224 units/l in those without a clinical fistula (P = 0·001). Patients with a PF had a higher lipase concentration than those without: 7852 versus 64 units/l (P < 0·001). A lipase level higher than 500 units/l yielded a sensitivity of 88 per cent and a specificity of 75 per cent for PF. For clinical fistulas the sensitivity was 93 per cent and specificity 77 per cent when the threshold for lipase was 1000 units/l. Conclusion: Lipase concentration in the abdominal drain correlated with PF. A threshold of 1000 units/l yielded a high sensitivity and specificity for the diagnosis of clinical PF.
- 27 April 2012
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 99 (8) , 1072-1075
Open AccessDiagnosis of postoperative pancreatic fistula
Background: Pancreatic fistula (PF) is a major source of morbidity after pancreatectomy. The International Study Group on Pancreatic Fistula (ISGPF) defines postoperative fistula by an amylase concentration in the abdominal drain of more than three times the serum value on day 3 or more after surgery. However, this definition fails to identify some clinical fistulas. This study examined the association between lipase measured in abdominal drainage fluid and PF. Methods: Amylase and lipase levels in the abdominal drain were measured 3 days after pancreatic resection. Grade B and C fistulas were classified as clinical fistulas, regardless of whether the measured amylase concentration was considered positive or negative. The PF group included patients with a clinical fistula and/or those with positive amylase according to the ISGPF definition. Results: Sixty-five patients were included. The median level of lipase was higher in patients with positive amylase than in those with negative amylase: 12 176 versus 64 units/l (P < 0·001). The lipase level was 16 500 units/l in patients with a clinical fistula and 224 units/l in those without a clinical fistula (P = 0·001). Patients with a PF had a higher lipase concentration than those without: 7852 versus 64 units/l (P < 0·001). A lipase level higher than 500 units/l yielded a sensitivity of 88 per cent and a specificity of 75 per cent for PF. For clinical fistulas the sensitivity was 93 per cent and specificity 77 per cent when the threshold for lipase was 1000 units/l. Conclusion: Lipase concentration in the abdominal drain correlated with PF. A threshold of 1000 units/l yielded a high sensitivity and specificity for the diagnosis of clinical PF.
- Open Access
- 6 February 2012
- Published by Springer Nature in World Journal of Surgical Oncology
- Vol. 10 (1) , 29
High-pressure intrapleural chemotherapy: feasibility in the pig model
The usual treatments for pleural malignancies are mostly palliative. In contrast, peritoneal malignancies are often treated with a curative intent by cytoreductive surgery and intraperitoneal chemotherapy. As pressure has been shown to increase antitumor efficacy, we applied the concept of high-pressure intracavitary chemotherapy to the pleural space in a swine model.
- 6 February 2012
- Published by Springer Nature in World Journal of Surgical Oncology
- Vol. 10 (1) , 29
Open AccessHigh-pressure intrapleural chemotherapy: feasibility in the pig model
The usual treatments for pleural malignancies are mostly palliative. In contrast, peritoneal malignancies are often treated with a curative intent by cytoreductive surgery and intraperitoneal chemotherapy. As pressure has been shown to increase antitumor efficacy, we applied the concept of high-pressure intracavitary chemotherapy to the pleural space in a swine model.